Literature DB >> 955868

Preeclampsia and fetal well-being.

E Sadovsky, Y Aboulafia, A Milwidsky, D Weinstein, W Z Polishuk.   

Abstract

Thirty-three women with preeclamptic toxemia were retrospectively divided into three groups, according to clinical data, urinary estriol excretion, fetal growth, fetal movements and fetal heart recordings. In group 1 (six patients) there was no fetal growth retardation, and fetal motor function and heart rate were normal. In group 2 (17 patients) there was fetal growth retardation, estriol values were usually low, and fetal movements and heart rate were normal. In group 3 (10 patients) fetal movements decreased markedly almost until complete cessation for 12 to 24 h, and pathological changes were present in fetal heart recordings. A classification of preeclamptic toxemia according to these criteria is suggested. Patients who manifest placental metabolic failure, such as the women in group 2, should be hospitalized for observation only, as no immediate danger to the fetus is apparent. If there are signs of severe fetal distress and cardiomotor failure, such as in group 3, prompt delivery is essential to prevent fetal death in utero.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 955868

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  2 in total

1.  Reduced uterine perfusion pressure induces hypertension in the pregnant mouse.

Authors:  Suttira Intapad; Junie P Warrington; Frank T Spradley; Ana C Palei; Heather A Drummond; Michael J Ryan; Joey P Granger; Barbara T Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-10-08       Impact factor: 3.619

2.  Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in Mice.

Authors:  Tomofumi Fushima; Akiyo Sekimoto; Takahiro Minato; Takuya Ito; Yuji Oe; Kiyomi Kisu; Emiko Sato; Kenichi Funamoto; Toshiyuki Hayase; Yoshitaka Kimura; Sadayoshi Ito; Hiroshi Sato; Nobuyuki Takahashi
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.